Member Info for alwayswinning

What part of my comment do you disagree with in particular? My anger is directed solely at Smith, not at "their people" as you put it.

The problem is, this Medusa company doesn't even have a distrobution network yet as far as I can tell. Why hand over a product that is literally the most important item in the world today to some twhat who has knocked up a shzitty website a few hours earlier. This is a bit like inventing a time machine and giving exclusivity right to Derek down the market who has a stall selling cheap batteries. One of the most rotten things I've seen in all my time on this bent market.

....................has a great deal of explaining to do here. The potential here was out of this world and he hands over exclusivity rights to some fella' who took a huge lump of the company under dodgy circumstances as it was. The good news is we are going to have our product distributed by a company that barely exists and now has exclusive rights to our products? C'mon Smithy boy where are ya', ya' fecker.

As I mentioned yesterday. This needed sorting before AVCT released any more news on testing. Makes life much more difficult for GDR and will weigh on the SP again. AVCT were miles behind GDR on the testing front, but now they seem to be moving at lightning speed on both the PCR and POC front. GDR need to chuck a shape.

In all seriousness they need to hurry up and get this approved and get the orders in now. Most eyes will be on the antigen tests, so it would be better if GDR could get something sorted before any more comes to light about the POC tests.

Just heard the Titanic's gone for a burton. Tragic stuff.

Just a quick heads up. Not sure if it will effect the wider market, but Queen Victoria is dead and someone in the know mentioned there's a virus going about or something. Defo DYOR though.

PMSL

I said last month 30p looked likely over the coming weeks. Taken a few for a punt down here, but still could go anywhere without some decent news.

I think Avacta will definitely lead the way and scoop up an incredible share of the market in the process. Antibody tests will not outstrip the sale of antigen tests IMO. The only accurate antibody test is via a blood sample. Saliva tests for antibodies would be very inaccurate. Therefore given the speed, non-invasive nature and accuracy of a saliva based antigen test, this is going to potentially be one of the most incredible stories on AIM over the coming months.

The Affirma platform should IMO dominate the entire space fairly soon. Avacta will have few overheads, and no manufacturing or distribution concerns. Just a case of them raking in the royalties from their superior platform.

I'm also encouraged to see them broadening out much further. Yesterdays RNS shows they are not just looking to dominate one aspect of the testing space but almost every area of it and the Affirma platform gives them every opportunity to do that. I can seriously see Avacta becoming a diagnostic superpower over the coming months.

Companies with this much potential are valued in the multiple billions on the NASDAQ. IMO people will cotton on soon enough. Save for any catastrophes, this could be over a billion much much sooner than people think.

Compare Avacta to NCYT. NCYT has traded around 500m. AVCT is a much more solid company with more strings to it's bow than NCYT will ever have. At this moment in time NCYT is dominating the testing space and we must take that into account. We are literally weeks away from AVCT getting to the stage where it's product is being produced and rolled out infinitely more than NCYT's product is. It all hinges on the results and confirmation that AVCT's test is the real deal and we're off to the races. Given all of that you would expect AVCT to be trading at many multiples of NCYT once it is up to speed.

.........The clue is in the ticker symbol really isn't it. This has to be in the top ten worst stocks I've encountered in the last ten years.

No discernible revenues or way forward, a death spiral financing agreement that would make even the most battle hardened AIM investor burst into tears and this it's run by a combination of inexperienced yobs and a serial azzhole. What a peach of a stock. I know what people will say to that, Unilad this, Unilad that. This isn't Unilad. These idiots have never run a real company before but they've been tutored by the best on how to run one into the ground over the last year. Good old David Sefton.

Makes me laugh when Justin Waite asks Quinlan three reasons for people to invest every time he has him on the show. You can almost sense he wants to burst out into hysterics but just manages to keep it together.

"LTHs 3-5 months and i reckon most of you will be back in profit.
Be bold HOLD"

People were saying it would be 5p in 12 months time, and that was 18 months ago applegarth.

What makes you think anything will change in 3-5 months time?

To be clear, although I'm not confident of this companies prospects in the long term. I do believe it could bounce well at some point. Doesn't look ready to bounce yet though, hence my opinion smart money is likely waiting for lower.

I know the 30p was offered to people who already held, but that doesn't mean they won't be offloading them for a quick profit. Some of course with much higher averages may hold, hence another reason why I can't see it getting all the way down to 30p, but given the selling pressure that has prevailed for months on end 40p is not in the realms of fantasy.

As I said, until those 30p shares have been offloaded that level will continue to be a magnet. Also as I said, it's unlikely it will get that low given there will continue to be more and more people moving in the nearer to 30p it gets. I'm guessing 35-40p may prove to be the bottom, though it's possible it could bottom somewhere in the low 40's. 50p is being tested and looks very shaky, that's all I know from the current price action. Make up your own mind where you think this is going of course.

This has only gone one way for months on end now, so the most obvious place it will find support is close to 30p at this time IMO. Now I doubt it will get that low, but it could get down to the 35p-40p range IMO. That's where the smart traders will start moving in IMO.

Those 30p shares will keep this rooted to the ground for the foreseeable IMO. Today's RNS was likely to help churn through a few of them.

Revenue is not profit.

Where did you read that?

Which was partially my point earlier. I said "assuming" £1 per test, but as I then pointed out. We don't know what ODX will be making out of this. I would also point out that CEO's and the rest of the socialite types have a habit of being extremely charitable when they want to be, especially with other peoples money.